Video
Author(s):
This new medication is a huge leap forward for treating attention-deficit/hyperactivity disorder.
Ann Childress, MD, talks about Qelbree and the importance of its approval by the US Food and Drug Administration.
Dr Childress is a practicing psychiatrist with a subspecialty in child and adolescent psychiatry, clinical researcher, and president of the Center for Psychiatry and Behavioral Medicine, Inc. in Las Vegas.
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.